Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination
Clinical trial NCT07154810 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07154810
- Sponsor
- SpyGlass Pharma, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-16
- Primary completion
- 2031-04-14
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.